Professor Marcin Ufnal
AstraZeneca, Gothenburg (Sweden)
AZD3427, a relaxin mimetic in pulmonary hypertension group 2 associated with left heart disease: design and rationale of the phase 2b Re-PHIRE Study
Event: Heart Failure 2024
Topic: Pharmacotherapy
Session: ePosters in chronic heart failure - treatment 5
Safety, pharmacokinetics, and pharmacodynamics of AZD3427, a functionally selective long acting relaxin mimetic agonist of the RXFP1 receptor
Event: Heart Failure 2023
Topic: Pharmacotherapy
Session: Chronic heart failure - pharmacotherapy 6
